The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: -2.30 (-8.36%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 25.20
Low: 25.20
Prev. Close: 27.50
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

13 Jan 2020 07:00

RNS Number : 5132Z
KRM22 PLC
13 January 2020
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Trading update

 

KRM22 plc (AIM: KRM.L) announces a trading update for the 12month period to 31 December 2019 ("FY2019").

 

The Company expects to report a FY2019 full year performance of Adjusted EBITDA loss in line with market expectations, from recognised revenue of approximately £4.0m (2018 £1.3m). A small number of contract signings were slightly delayed and have fallen into the new financial year, which the Company expects to close imminently.

 

The Company has ARR of £4.5m (2018 £3.3m) as at FY2019 at the 2019 constant exchange rate (£4.3m at current rates). This reflects an 18% organic growth rate for FY2019. Sterling's recent strengthening has had a negative impact on contracted ARR as well as the FY2019 revenue, but slight positive impact on adjusted EBITDA loss. Included in the ARR, as at the FY2019, is £0.3m contributed by an existing customer that has recently been acquired by a third party and the Company is working with the new owner to continue the relationship and potentially to provide additional services.

 

The Company continues to have a strong pipeline of prospects, including deals commercially agreed but in the process of being contracted, and remains focused on driving organic growth during FY2020. Cash at 31 December 2019 was £1.0m.

 

The action taken during 2019 to reduce the cost base combined with the increase in ARR and strong sales pipeline has ensured the Company is on track to be adjusted EBITDA profitable and cash flow positive in 2020.

 

Keith Todd, Executive Chairman and CEO at KRM22, commented: "In the last twelve months we have seen KRM22 making significant progress. The 'Global Risk Platform', which is the central pillar of our strategy, is live and provides access to multiple offerings including our Enterprise Risk Cockpit, Market Risk and Regulatory Risk suite. We are confident that we are on course in 2020 to deliver on our commitments."

 

 

For further information please contact:

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Matthew Radley

Alice Lane / Sunila de Silva (ECM)

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 PLC is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFIFLTLRIFLII
Date   Source Headline
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting
21st Jul 20237:00 amRNSDirector Dealing
20th Jul 20237:00 amRNSHalf Year Trading Update
4th Jul 20237:00 amRNSPosting of Accounts, Circular and Notice of GM
30th Jun 202312:41 pmRNSResult of AGM
27th Jun 20237:00 amRNSFinal Results
19th Jun 20237:00 amRNSNew Debt Facility
8th Jun 20237:00 amRNSAnnual Report and Notice of AGM
16th Dec 20223:15 pmRNSIssue of Options
20th Sep 20227:00 amRNSInterim Results
13th Jun 202210:00 amRNSHolding(s) in Company
5th May 202212:00 pmRNSResult of AGM
20th Apr 20222:30 pmRNSDirector Dealing
12th Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
7th Apr 20224:30 pmRNSHolding(s) in Company
28th Mar 20225:30 pmRNSHolding(s) in Company
23rd Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSProduct Launch Under Distribution Agreement
1st Mar 20227:00 amRNSUpdate re Annual Results (Change of Date)
31st Jan 20227:00 amRNSTrading Update
5th Jan 202210:47 amRNSHolding(s) in Company
30th Dec 20219:47 amRNSSubscription Completion, Executive Changes and TVR
22nd Dec 20217:00 amRNSSubscription Update
22nd Nov 20217:00 amRNSHolding(s) in Company
1st Nov 20217:00 amRNSSubscription Agreement and Trading Update
20th Oct 20213:43 pmRNSHolding(s) in Company
16th Sep 20212:38 pmRNSDirector/PDMR Shareholding
13th Sep 20219:52 amRNSDirector/PDMR Shareholding
10th Sep 20212:48 pmRNSDirector/PDMR Shareholding
8th Sep 202112:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
1st Sep 20217:00 amRNSInterim Results
30th Jul 20217:00 amRNSContract Extension
22nd Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20217:00 amRNSKRM22 announces partnership with Waymark Tech
28th Apr 20211:29 pmRNSResult of AGM
19th Apr 20217:00 amRNSExercise of options and total voting rights
26th Mar 20213:24 pmRNSHolding(s) in Company
23rd Mar 20218:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20215:39 pmRNSHolding(s) in Company
16th Mar 202111:06 amRNSTechnology Demonstration
16th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSKRM22 announces new partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.